EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, DTIL:

06 Oct 25 19:37
LAST:

5.600

CHANGE:
 0.16		OPEN:
5.500		HIGH:
5.768		ASK:
0.000		VOLUME:
122.7K
CHG(%):
2.94		PREV:
5.440		LOW:
5.073		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Oct 255.4405.7685.3965.670144.8K
03 Oct 255.4405.4505.3655.44085.9K
02 Oct 255.4005.4505.2605.42054.5K
01 Oct 255.4105.5605.4105.440104.4K
30 Sep 255.1805.5505.1405.520189.8K
29 Sep 255.1405.1555.0005.090129.5K
26 Sep 254.9505.0904.9305.06056.2K
25 Sep 255.0105.1124.9004.93045.1K
24 Sep 254.9205.1604.9205.130161.6K
23 Sep 254.8604.9804.8304.88041.8K

COMPANY PROFILE

Name:Precision Biosciences Inc
About:Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Sector:Healthcare
Industry:Biotechnology
Address:302 East Pettigrew St., Durham, NC, United States, 27701
Website:https://precisionbiosciences.com
CUSIP:74019P108
CIK:0001357874
ISIN:US74019P2074
FIGI:BBG008NSBPV3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:5.48
MA10:5.25
MA20:5.02
MA50:4.91
MA100:4.82
MA200:4.92
STO9:79.92
STO14:86.41
RSI14:72.46
MTM14:1.07
ROC14:0.24
ATR:0.27
Week High:5.77
Week Low:5.00
Month High:5.77
Month Low:4.50
Year High:9.55
Year Low:3.61
Volatility:25.76

RECENT SPLITS

Date Ratio
14 Feb 20241-30